CrkL antibody (pTry207)
Quick Overview for CrkL antibody (pTry207) (ABIN645839)
Target
See all CrkL (CRKL) AntibodiesReactivity
Host
Conjugate
Application
-
-
Binding Specificity
- pTry207
-
Specificity
- The Goat anti-CRKL antibody detects protein derived from human recombinant protein and K562 lysate at various concentrations.
-
Cross-Reactivity
- Human, Mouse (Murine), Rat (Rattus)
-
Characteristics
- Goat Anti-CRKL
-
Immunogen
- Synthetic peptide with sequence C-KIFDPQNPDENE, from the C Terminus of the protein sequence according to NP_005198, was used as immunogen.
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Supplied as 100µg of purified antibody 0.5mg/ml in Tris saline, 0.02% sodium azide, pH 7.3 with 0.5% bovine serum albumin. Please avoid freeze-thaw cycles.
-
Storage
- -20 °C
-
-
- CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))
-
Alternative Name
- CRKL
-
Background
- Anti-Crkl antibody is a 33kDa adaptor protein that has been shown to activate the RAS and JUN kinase signalling pathways. Also transforms fibroblasts in a RAS dependant manner. Crkl is a substitute of BCR ABL tyrosine kinase. In addition, Crkl has oncogenic potential, and may mediate the transduction of intracellular signals.
-
NCBI Accession
- NP_005198
-
Pathways
- Interferon-gamma Pathway, Neurotrophin Signaling Pathway, Signaling of Hepatocyte Growth Factor Receptor
Target
-